Managing Impending Non-Severe Hypoglycemia with Oral Carbohydrates in Type 1 Diabetes: The REVERSIBLE Trial. by Ran Cheng (8449275)

“…Following inpatient subcutaneous insulin-induced decrease in BG in the fasting state, 16g of oral CHO was administered at a plasma glucose (PG) of <70 mg/dL (3.9 mmol/L), ≤80 mg/dL (4.5 mmol/L) or ≤90 mg/dL (5.0 mmol/L). …”

Loss of <i>bmm</i> function in the somatic cells of the gonad with an independent GAL4 line affects whole-body triglyceride breakdown in males but not females. by Lianna W. Wat (8339454)

“…(D) Triglyceride breakdown post-starvation among 5-day-old virgin <i>tj>UAS-bmm-RNAi</i> females and <i>tj>+</i> and <i>+>UAS-bmm-RNAi</i> control females was modestly decreased by a similar magnitude at both 0–12 hours or 12–24 hours STV (<i>p</i> = 0.058, 0.026, and 0.022 for 0–12 hours and 0.042, 0.0093, and 3.7 × 10⁻⁴ for 12–24 hours, respectively; one-way ANOVA followed by Tukey HSD test). …”

DataSheet2_Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer... by Mohamed S. Nafie (9754305)

“…Conversely, compounds 5a-f displayed promising cytotoxicity against MCF-7 cells with IC₅₀ values range (IC₅₀ = 5.87–18.5 μM) with selective activity against MDA-MB-231 cancer cells. …”

DataSheet1_Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer... by Mohamed S. Nafie (9754305)

“…Conversely, compounds 5a-f displayed promising cytotoxicity against MCF-7 cells with IC₅₀ values range (IC₅₀ = 5.87–18.5 μM) with selective activity against MDA-MB-231 cancer cells. …”

Dfos increases Rho1-GTP, the formin Diaphanous and actin at the cortex through Cher and TM4SF. by Vera Belyaeva (11914218)

“…<i>TM4SF RNAi</i> *<i>p</i> = 0.024 or 0.026 (20% reduction). SD: 1.9, 0.9, 1.0, 0.9, 1.0 in N; 0.7, 0.5, 0.5, 0.5, 0.4 in P. …”